Fruit intake associated with urinary estrogen metabolites in healthy premenopausal women

DOI: 10.4236/ojpm.2012.21001   PDF   HTML     3,979 Downloads   7,259 Views   Citations


Urinary concentrations of 2:16-hydroxyestrone (2:16-OHE1) approximate concentrations of 2-OHE1 and 16α-OHE1 in breast tissue. As estrogens are purported to be involved in breast cancer development, the 2:16-OHE1 ratio can provide an indication of estrogen metabolite exposure in the breast. With prior studies observing associations between urinary estrogen metabolites and dietary intakeof fruits, vegetables, and fiberascertained from food questionnaires, we examined associations between dietary factors ascertained through 3-day food records and urinary 2:16-OHE1 in191 pre-menopausal healthy women. Fruit consumption was positively associated with 2:16-OHE1 after adjustment for total energy, ethnicity, body mass index, parity, smoking history, and serum estradiol (p = 0.003). Fruit consumption was positively associated with 2-OHE1 concentrations (p = 0.006), but was not associated with 16α-OHE1 (p = 0.92). The Musaceae botanical grouping (comprised primarily of bananas) was positively associated with the 2:16-OHE1 ratio, and Rosaceae (comprised of citrus fruits) and Musaceae botanical groupings were positively associated with 2-OHE1 (but not 16α-OHE1) concentrations, after adjustment for confounders. Our data suggest that dietary fruit intakeis associated with urinary 2-OHE1 and the 2:16-OHE1 ratio and that breast tissue exposure to estrogen metabolites may thus be influenced-by diet.

Share and Cite:

Reding, K. , Atkinson, C. , Westerlind, K. , Stanczyk, F. , Bowles, E. , Yong, M. , Newton, K. and Lampe, J. (2012) Fruit intake associated with urinary estrogen metabolites in healthy premenopausal women. Open Journal of Preventive Medicine, 2, 1-8. doi: 10.4236/ojpm.2012.21001.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Thomas, H.V., Reeves, G.K. and Key, T.J. (1997) Endogenous estrogen and postmenopausal breast cancer: A quantitative review. Cancer Causes and Control, 8, 922-928. doi:10.1023/A:1018476631561
[2] Dallal, C. and Taioli, E. (2010) Urinary 2/16 estrogen metabolite ratio levels in healthy women: A review of the literature. Mutation Research, 705, 154-162. doi:10.1016/j.mrrev.2010.06.004
[3] Goth-Goldstein, R., Erdmann, C.A. and Russell, M. (2003) Cytochrome P4501B1 expression in normal breast tissue. Polycyclic Aromatic Compounds, 23, 259-275. doi:10.1080/10406630308051
[4] Seow, A., Vainio, H. and Yu, M.C. (2005) Effect of glutathione-S-transferase polymorphisms on the cancer preventive potential of isothiocyanates: An epidemiological perspective. Mutation Research, 592, 58-67. doi:10.1016/j.mrfmmm.2005.06.004
[5] Saracino, M.R. and Lampe, J.W. (2007) Phytochemical regulation of UDP-glucuronosyl transferases: Implications for cancer prevention. Nutrition and Cancer, 59, 121-141. doi:10.1080/01635580701458178
[6] Moon, Y.J., Wang, X. and Morris, M.E. (2006) Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicology in Vitro, 20, 187-210. doi:10.1016/j.tiv.2005.06.048
[7] Sepkovic, D.W. and Bradlow, H.L. (2009) Estrogen hydroxylation—The good and the bad. Annals of the New York Academy of Sciences, 1155, 57-67. doi:10.1111/j.1749-6632.2008.03675.x
[8] Zahid, M., et al. (2006) The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: Implications for tumor-initiating activity. Chemical Research in Toxicology, 19, 164-172. doi:10.1021/tx050229y
[9] Fishman, J. and Martucci, C. (1980) Biological properties of 16 alpha-hydroxyestrone: Implications in estrogen physiology and pathophysiology. The Journal of Clinical Endocrinology & Metabolism, 51, 611-615. doi:10.1210/jcem-51-3-611
[10] Clark, J.H., Paszko, Z. and Peck Jr., E.J. (1977) Nuclear binding and retention of the receptor estrogen complex: Relation to the agonistic and antagonistic properties of estriol. Endocrinology, 100, 91-96. doi:10.1210/endo-100-1-91
[11] Eliassen, A.H., et al. (2008) Circulating 2-hydroxy and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention, 17, 2029-2035. doi:10.1158/1055-9965.EPI-08-0262
[12] Arslan, A.A., et al. (2009) Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer Epidemiology, Biomarkers & Prevention, 18, 2273-2279. doi:10.1158/1055-9965.EPI-09-0312
[13] Ursin, G., et al. (1997) A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environmental Health Perspectives, 105, 601-605.
[14] Taioli, E., et al. (2010) Comparison of estrogens and estrogen metabolites in human breast tissue and urine. Reproductive Biology and Endocrinology, 8, 93. doi:10.1186/1477-7827-8-93
[15] Sowers, M.R., et al. (2006) Selected diet and lifestyle factors are associated with estrogen metabolites in a multiracial/ethnic population of women. Journal of Nutrition, 136, 1588-1595.
[16] Jernstrom, H., et al. (2003) Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis, 24, 991-1005. doi:10.1093/carcin/bgg047
[17] Aubertin-Leheudre, M., et al. (2008) Fat/fiber intakes and sex hormones in healthy premenopausal women in USA. The Journal of Steroid Biochemistry and Molecular Biology, 112, 32-39. doi:10.1016/j.jsbmb.2008.08.002
[18] Klug, T.L., et al. (2006) Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: A pilot study comparing pre- and post-operative levels. Molecular Genetics and Metabolism, 89, 381-389. doi:10.1016/j.ymgme.2006.08.005
[19] Lu, F., et al. (2008) Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prevention Research, 1, 135-145. doi:10.1158/1940-6207.CAPR-08-0037
[20] Ciolino, H.P., Daschner, P.J. and Yeh, G.C. (1999) Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochemical Journal, 340, 715-722. doi:10.1042/0264-6021:3400715
[21] Chen, Y., et al. (2009) Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers. Clinical and Experimental Pharmacology and Physiology, 36, 828-833. doi:10.1111/j.1440-1681.2009.05158.x
[22] Zendulka, O., et al. (2008) The Influence of Trans-resveratrol and Quercetin on the Activity of CYP1A2 in Rat. Czech Journal of Food Sciences, 26, S60-S64.
[23] Hayes, J.D., Kelleher, M.O. and Eggleston, I.M. (2008) The cancer chemopreventive actions of phytochemicals derived from glucosinolates. European Journal of Nutrition, 47, 73-88. doi:10.1007/s00394-008-2009-8
[24] Ito, S., et al. (2007) Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. Journal of Clinical Investigation, 117, 1940-1950. doi:10.1172/JCI31647
[25] Jellinck, P.H., et al. (1993) Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochemical Pharmacology, 45, 1129-1136. doi:10.1016/0006-2952(93)90258-X
[26] Atkinson, C., et al. (2008) Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States. The American Journal of Clinical Nutrition, 87, 679-687.
[27] Atkinson, C., et al. (2008) Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. Cancer Causes and Control, 19, 1085-1093. doi:10.1007/s10552-008-9172-3
[28] Stanczyk, F.Z., et al. (2003) Limitations of direct estradiol and testosterone immunoassay kits. Steroids, 68, 1173-1178. doi:10.1016/j.steroids.2003.08.012
[29] Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B, 57, 289-300.
[30] Longcope, C., et al. (1987) The effect of a low fat diet on estrogen metabolism. The Journal of Clinical Endocrinology & Metabolism, 64, 1246-1249. doi:10.1210/jcem-64-6-1246
[31] Haggans, C.J., Hutchins, A.M., Olson, B.A., Thomas, W., Martini, M.C. and Slavin, J.L. (1999) Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutrition and Cancer, 33, 188-195. doi:10.1207/S15327914NC330211
[32] Lu, L.J., et al. (2000) Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Research, 60, 1299-1305.
[33] Bradlow, H.L., et al. (1994) Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiology, Biomarkers & Prevention, 3, 591-595.
[34] Mazur, W.M., et al. (2000) Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects. British Journal of Nutrition, 83, 381-387.
[35] Kristal, A.R., Peters, U. and Potter, J.D. (2005) Is it time to abandon the food frequency questionnaire? Cancer Epidemiology, Biomarkers & Prevention, 14, 2826-2828. doi:10.1158/1055-9965.EPI-12-ED1
[36] Yang, Y.J., et al. (2010) Relative validities of 3-day food records and the food frequency questionnaire. Nutrition in Clinical Practice, 4, 142-148.
[37] Day, N., et al. (2001) Epidemiological assessment of diet: A comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. International Journal of Epidemiology, 30, 309-317. doi:10.1093/ije/30.2.309
[38] Westerlind, K.C., Gibson, K.J. and Wolfe, P. (1999) The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: Implications for disease-risk assessment. Steroids, 64, 233-243. doi:10.1016/S0039-128X(98)00081-6
[39] Bradlow, H.L., et al. (2006) Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites. Molecular Genetics and Metabolism, 87, 135-146. doi:10.1016/j.ymgme.2005.08.001
[40] Williams, A.E., et al. (2002) The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women. BMC Womens Health, 2, 13.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.